← Eichor
Condition: Epp Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Epp

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Longitudinal Study of the Porphyrias
Phase N/A · 16 location(s) · The American Porphyrias Expert Collaborative · NCT01561157Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)
Phase N/A · 19 location(s) · Portal Therapeutics, Inc. · NCT07567131Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Proto
Phase 3 · 51 location(s) · Tanabe Pharma America, Inc. · NCT05005975
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.